Bexarotene is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is Bexarotene.
| Product ID | 42292-007_7cef9597-58f6-339f-e053-2991aa0a1efb |
| NDC | 42292-007 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bexarotene |
| Generic Name | Bexarotene |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-04-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203174 |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | BEXAROTENE |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2016-04-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA203174 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-04-15 |
| Marketing End Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA203174 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-04-15 |
| Marketing End Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| BEXAROTENE | 75 mg/1 |
| SPL SET ID: | 9410215d-828c-454c-a44e-ad0fb0c65f68 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0399 | Bexarotene | bexarotene |
| 0378-6955 | Bexarotene | Bexarotene |
| 0591-2832 | bexarotene | bexarotene |
| 0832-0285 | Bexarotene | Bexarotene |
| 42292-007 | Bexarotene | Bexarotene |
| 43975-315 | Bexarotene | Bexarotene |
| 68682-002 | bexarotene | bexarotene |
| 68682-003 | bexarotene | bexarotene |
| 69238-1250 | Bexarotene | Bexarotene |
| 69238-2088 | Bexarotene | Bexarotene |
| 0187-5525 | Targretin | bexarotene |
| 0187-5526 | Targretin | bexarotene |